Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's Perspective

The quality of survivorship after hematopoietic stem cell transplantation (HCT) is determined not only by cure of the disease for which the transplant was performed but also by the resumption of previous roles within the family, the community and the workplace.1 For many patients, return to work (RTW) serves as a metric of recovery from treatment and signifies the return to an identity beyond “patient,” and a positive step toward the future.1,2 HCT, which may be the only curative treatment for many patients with hematologic disorders, may result in failure to RTW and prolonged work limitations for treatment-related complications.

Source: Biology of Blood and Marrow Transplantation - March 30, 2024 Category: Hematology Authors: Rachel B. Salit, Stephanie J. Lee, Neel S. Bhatt, Paul A. Carpenter, Xinyi Fan, Ailie Armstrong, Masumi Ueda Oshima, Laura Connelly-Smith, Elizabeth Krakow, Catherine J. Lee, Phuong Vo, Rohtesh Mehta, Karen L. Syrjala Source Type: research